Aurobindo Pharma USA Inc. et al. vs. Andrx Labs, LLC et al.
Explore the PTAB proceeding IPR2017-01648 filed by Aurobindo Pharma USA Inc. et al. on 2017-06-22. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-01648
Filing Date
2017-06-22
Accorded Filing Date
2017-06-22
Institution Decision Date
2017-12-29
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2018-12-28
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Aurobindo Pharma USA Inc. et al.
Represented By
Moore, Stevenet alPatent Owner / Respondent
Andrx Labs, LLC et al.
Represented By
Cavanaugh, Davidet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions